Hartland & Co »

Oncolytics Biotech shares owned by Hartland & Co

Quarter-by-quarter ownership of Oncolytics Biotech (ONCY) shares owned by Hartland & Co from 13F filings

Historical chart of Hartland & Co investment in Oncolytics Biotech

Tip: Access up to 7 years of quarterly data

All positions including Oncolytics Biotech held by Hartland & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Oncolytics Biotech by Hartland & Co

Quarter filed Position value Share count Share price at filing
2026-06-30 $37k 39k 0.95

More positions owned by Hartland & Co

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr Core S&p500 Etf (IVV)
Apple Put Put Option (Principal) (AAPL)
Paccar (PCAR)
Ishares Tr Rus 1000 Grw Etf (IWF)
Vanguard Index Fds Mid Cap Etf (VO)
Microsoft Corporation (MSFT)
Vanguard Index Fds Small Cp Etf (VB)
Vanguard Index Fds Value Etf (VTV)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Spdr Index Shs Fds St Str Po Ex Etf (SPDW)
Amazon Call Call Option (AMZN)
Vanguard Scottsdale Fds Mtg-bkd Secs Etf (VMBS)
Ishares Tr Core Msci Intl (IDEV)
Vanguard Index Fds Call Call Option (VTI)

View all positions for Hartland & Co

Top funds holding Oncolytics Biotech

Marshall Wace
Everhart Financial Group
PFG Investments
Doliver Capital Advisors
Fifth Third Bancorp
Badgley Phelps Wealth Managers
Hartland & Co
Commonwealth Equity Services
Professional Advisory Services
Branch Banking & Trust Company
Victory Capital Management
AlphaCore Capital
Valley National Advisers
Cambridge Investment Research Advisors
Cedar Mountain Advisors

View all funds holding Oncolytics Biotech